首页 › 基金 › Michelson Medical Research Foundation, Inc. › VEA

Michelson Medical Research Foundation, Inc. 对 VEA 的持仓历史

VANGUARD TAX-MANAGED FDS

Michelson Medical Research Foundation, Inc. 在 Q3 2026 的 13F 申报中披露持有 VEA(VANGUARD TAX-MANAGED FDS)158,160 股,市值约 US$11.2M,约占其申报组合的 9.93%,在其申报持仓中市值排名第 3 位。 Michelson Medical Research Foundation, Inc. 最近 13 个申报季度中有 13 个季度披露了 VEA 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)158.16K 股
申报持仓市值$11.17M
组合权重9.93%
首次申报Q3 2023
最近变动持有
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Michelson Medical Research Foundation, Inc. 对 VEA 的持仓演变

Michelson Medical Research Foundation, Inc. 于 Q3 2023 首次披露 VEA 持仓:361,160 股(约 US$15.8M)。 该持仓在 Q3 2024 达到峰值 361,160 股,市值约 US$19.1M。 在 13 次申报中,Michelson Medical Research Foundation, Inc. 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 158,160 股、市值约 US$11.2M。 持仓曾出现大幅变动:Q4 2024 减持约 56% (随后一个季度股价上涨 7%)。

逐季持仓明细

季度股数金额变化
Q3 2023 361.16K $15.79M 新进
Q4 2023 361.16K $7.30M 持有
Q1 2024 361.16K $18.12M 持有
Q2 2024 361.16K $17.85M 持有
Q3 2024 361.16K $19.07M 持有
Q4 2024 158.16K $7.56M 减持
Q1 2025 158.16K $8.04M 持有
Q2 2025 158.16K $9.02M 持有
Q3 2025 158.16K $9.48M 持有
Q4 2025 158.16K $9.88M 持有
Q1 2026 158.16K $10.13M 持有
Q2 2026 158.16K $11.27M 持有
Q3 2026 158.16K $11.17M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VEA 与 13F 数据

VEA(VANGUARD TAX-MANAGED FDS)的行业分类暂缺。我们追踪的基金中还有 30 只申报持有 VEA,申报仓位最大的包括:美国银行 (US$14.25B), Betterment LLC (US$9.91B), Creative Planning (US$8.09B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VEA 的基金

查看 VEA 的全部基金持有人 →

常见问题

How long has Michelson Medical Research Foundation, Inc. held VEA?

Michelson Medical Research Foundation, Inc. has disclosed VEA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in VEA?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 158.16K shares of VEA (VANGUARD TAX-MANAGED FDS), valued at $11.17M, representing 9.93% of its reported portfolio and ranking #3.

Has Michelson Medical Research Foundation, Inc. been buying or selling VEA?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in VEA. The position peaked in Q3 2024 at 361.16K shares.

Which other funds hold VEA?

Other major institutional holders of VEA include 美国银行, Betterment LLC, Creative Planning, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.